AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06372223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH5030
Description: SPH5030 tablets：400mg,orally, Dosing in the fasted state followed by fed dosing.
Study NCT06372223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SPH5030
Description: SPH5030 tablets：400mg, orally, Dosing in the fed state followed by fasted dosing.
Study NCT05558592 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary supplementation with fresh oranges
Description: the subjects enrolled in this group, will have to consume 400gr of oranges Navelina net of waste / day / per person for a month. The oranges will be provided, to each participant, by the IRCCS Saverio de Bellis.
Study NCT05558592 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Balanced Diet without oranges
Description: the subjects enrolled in this group, will have to consume 400 gr of fruit (with the exception of citrus fruits) net of waste / day / per person for a month.
Study NCT05636969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation
Description: The multimodal prehabilitation programme will consist of 1) twice weekly, supervised exercise training at the hospital gym for approximately 12-16 weeks; 2) nutritional consultation and diet optimization and supplementation if needed; 3) individual or group-based psychological support.
Study NCT05504226 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
Description: To be orally administered once daily for 52 weeks.
Study NCT05504226 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Teneligliptin Placebo Oral Tablet
Description: To be orally administered once daily for 52 weeks. This arm will be switched to teneligliptin from week 24.
Study NCT05246501 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation
Description: A case scenario with a diagnosis of dementia was used in the study. The scenario consisted of preliminary preparation, implementation and evaluation parts. Psychiatric nursing laboratory practice was applied to the students in the scenario study group. An elderly female standard patient who was diagnosed with dementia took part in the scenario. During this simulation, students were expected to perform mental state examination of the patient, use therapeutic communication techniques and ensure environmental safety.
Study NCT05246501 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No simulation
Description: The students in the control group did not receive simulation training.
Study NCT04750954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT04750954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT
Study NCT04750954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium Lu 177 Dotatate
Description: Given IV
Study NCT04750954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04750954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peposertib
Description: Given PO
Study NCT05001152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: Taste assessment
Study NCT05035030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Odevixibat
Description: Odevixibat is a small molecule and selective inhibitor of IBAT.
Study NCT05695443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: This study investigates the effects of an intervention based on Motivational Interviewing (MI) on oral hygiene, oral cleaning routines, and attitudes towards own oral health. The first step is for the dental staff to ask open questions to the prisoner about their oral health or oral health behavior. The next step is to confirm to the prisoner what he or she is doing. The third step is called reflection. At this stage, dental staff tries to provide reflections on what the prisoner have said, for example by repeating what the prisoner have said or say the same using synonyms (simple reflection), by extracting the underlying opinion or feeling (complex reflection), or by illuminate both negative and positive sides of the situation (double sided reflection). The final step is to summarize the conversation. In addition, the intervention includes a change plan, in which the prisoner and dental staff agrees on specific behavior that the prisoner should follow based on the MI conversation.
Study NCT06374160 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Exercise
Study NCT06417255 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesiotape application
Description: The strips used for kinesiological taping can be applied by giving different shapes. These shapes are I, Y, X, ring (donut), rake and net
Study NCT06417255 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: foam roller application
Description: In the foam roller group, Actifoam brand non-serrated foam rollers with a size of 15x90 cm were used.
Study NCT05806814 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Description: Three doses of Sipuleucel-T, each containing a minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, given at week 0, 2, and 12-14.
Study NCT05924204 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: Application of photobiomodulation
Study NCT05924204 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Simulation of Photobiomodulation
Description: Simulation of photobiomodulation
Study NCT06355596 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual teaching
Description: Virtual teaching of laparoscopic skills
Study NCT06355596 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual teaching
Description: Virtual teaching of laparoscopic skills
Study NCT06283940 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise based cardiac rehabilitation (PT-X)
Description: Individually prescribed centralcirculatory aerobic exercise and muscular endurance training twice a week for 60 minutes each session over 12 weeks in a hospital-based setting, and two sessions of home-based exercise recorded in an exercise diary.
Study NCT06790264 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPi-46 PET/CT
Description: Study participants will undergo baseline assessments at enrollment with 68Ga-FAPi-46 PET/CT
Study NCT06790550 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Music will be played during the insulin injection process
Study NCT06791876 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurture and Play (NnP)
Description: The NnP group Intervention is a group-based, manualized parenting intervention initiated during pregnancy and continued into the postnatal period until infant age seven months. The program is designed to enhance parenting abilities focusing on three domains: Emotional availability, parental reflective functioning, and the ability to regulate own emotions. During NnP, the parents are supported in enhancing their emotional availability through caring and playing activities.~The intervention has been developed in Finland by Dr. Saara Salo and colleagues and tested in a randomized controlled trial among pregnant women with depression and it is now being implemented in Finland. The results from the study showed that mothers in the intervention group showed more emotional availability and higher levels of reflective functioning and experienced fewer depressive symptoms compared to mothers in the control group.
Study NCT06789627 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RPD with PEEK framework
Description: Indirectly CAD/CAM produced PEEK framework
Study NCT06789627 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: RPD with metallic framework
Description: Indirectly CAD/CAM produced metallic RPD
Study NCT06790225 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose-dependent Insulinotropic Polypeptide (GIP)
Description: Recombinant human GIP (1-42)
Study NCT06785363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pumped technique for ilio-lumbar ligament release
Description: Patient position: the patient lying supine or side lying Therapist position: standing on one side of patient. Hand grip: one hand placed on posterior region of iliac crest (close to attachment of ilio-lumbar ligament) while other hand stabilize the medial part of thigh. Therapist force: therapist pulling patient's thigh posteriorly.
Study NCT05253963 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure
Description: Continuous Positive Airway Pressure will be used during the second night of polysomnography .
Study NCT06785363 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hot Packs
Description: postnatal women will be treated by hot packs for 20 minutes three times per week for 8 weeks.
Study NCT06791434 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fixed Dose Combination Etoshine MR tablets
Description: Composition per tablet: Etoricoxib 60 mg + Thiocolchicoside 4 mg
Study NCT06791434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fixed Dose Combination Etoshine MR tablets
Description: Composition per tablet: Etoricoxib 60 mg + Thiocolchicoside 4 mg
Study NCT06791434 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Thin needle insertion
Study NCT06791434 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Exercises
Study NCT06791434 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Exercises
Study NCT06388421 — intervention group
Intervention type: OTHER
Intervention: Prospective study assessments
Description: Patients will complete prospective assessments at 6- and 12-month intervals for up to 5 years. There will be 1 check in at the first 3 months of enrollment. Follow up visits will include a ±45 day visit window. If an assessment is performed within 45 days of the visit window as part of the patient's standard of care, those values will be used in place of a prospective assessment.
Study NCT06019039 — intervention group
Intervention type: DRUG
Intervention: Normal Saline Flush
Description: Five milliliters of sterile saline will be administered as a flush through the needle while recording the color flow doppler images. The same procedure will be repeated with a slow injection of 5 mL of saline. The speed of injection will not be standardized.
Study NCT06019039 — intervention group
Intervention type: DEVICE
Intervention: Doppler
Description: All color flow Doppler images will be performed with a Phillips CX50 ultrasound machine using a 5.0 MHz a low frequency curvilinear US probe. A two-dimensional transverse interspinous view was used to visualize the posterior complex (ligamentum flavum, epidural space and dura). After loss of resistance to normal saline, the color flow Doppler function will be turned on to examine flow through the epidural needle tip.~The ultrasound probe was positioned in the transverse axis slightly below the epidural needle but still in the interspinous space .
Study NCT06273722 — intervention group
Intervention type: DEVICE
Intervention: Vivosight Multi-beam Swept-Source Frequency Domain OCT scanner
Description: Vivosight Multi-beam Swept-Source Frequency Domain OCT scanner (Michelson Diagnostics Maidstone, Kent, UK; resolution \<7.5 µm lateral, \<5 µm axial; depth of focus 1.0 mm; scan area 6 × 6 mm).
Study NCT04305769 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.
Study NCT04305769 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.
Study NCT06271265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXPAREL
Description: A single dose of EXPAREL Injectable Product via LIA
Study NCT06271265 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine
Description: A single dose of 0.25% bupivacaine via LIA
Study NCT06401889 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT05160233 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
Study NCT05160233 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.
Study NCT05160233 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching
Description: The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.
Study NCT05160233 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practice Facilitation
Description: A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
Study NCT05159167 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Baduanjin, a type of Qigong
Description: Baduanjin is very popular in China. There is increasing evidence to support its positive effects on health outcomes in various groups of people with physical and mental disorders.
Study NCT05159167 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin, a type of Qigong
Description: Baduanjin is very popular in China. There is increasing evidence to support its positive effects on health outcomes in various groups of people with physical and mental disorders.
Study NCT05151783 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy
Description: Control group receivewill routine physical therapy including modalities like ultrasound (3 MHz continuous type; duration 10 minutes), heat modalities (apply to the involved region of shoulder joint shoulder for 10 minutes), shoulder ROM exercises, capsular stretching, and joint mobilization 5 times per week for four weeks. Duration of session will be 40 minutes.~All Maitland mobilization will be given in supine position. After giving glenohumeral (GH) joint distraction, GH caudal glide, GH dorsal glide, and GH ventral glide were given at a rate of 2-3/second oscillations for 1-2 minutes to patients. Grade I or II rhythmic oscillations will be applied in pain free movement.
Study NCT05151783 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF technique
Description: Group will receive scapular PNF techniques with routine physical therapy explained above For PNF techniques, patients will be lying on unaffected shoulder. In this group, 20 repetitions of diagonal scapular Pattern (Anterior Elevation and Posterior Depression and Posterior Elevation and Anterior Depression) with 20 sec rest period will be given to patients. Preparatory instructions for the desired movement will be given to patients at the start of procedure. PNF facilitation techniques of RI (Rhythmic initiation) \& repeated contractions will be used in all patterns
Study NCT06002581 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS real stimulation stage1
Description: In the first stage, the early treatment group use low-frequency rTMS real stimulation,
Study NCT06002581 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: rTMS shame stimulation stage1
Description: In the first stage, the control group (delayed treatment group) all use sham stimulation.
Study NCT06002581 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: rTMS real stimulation stage 2
Description: In the second stage, both the early treatment group and the control group (delayed treatment group) will be treated with true stimulation low-frequency rTMS.
Study NCT06002581 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS real stimulation stage 2
Description: In the second stage, both the early treatment group and the control group (delayed treatment group) will be treated with true stimulation low-frequency rTMS.
Study NCT05127512 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Video
Description: A 6.47-minute education video was created by the research group based on American Urogynecology Society (AUGS) and International Urogynecologic Association (IUGA) patient education pamphlets. Participants in the intervention group will be asked to watch this video after completing a baseline knowledge questionnaire of pelvic floor disorders.
Study NCT05573724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5305
Description: In Part A, the participants will receive a single dose of AZD5305 on Day 1 and Day 7.~In Part B, the participants will receive AZD5305 once daily.
Study NCT05573724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: In Part A, the participants will receive Itraconazole twice daily on Day 4 and once daily on Days 5-12
Study NCT04941703 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Citrate plus probiotic
Description: 296 ml magnesium citrate
Study NCT04941703 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Magnesium Citrate plus probiotic
Description: 296 ml magnesium citrate
Study NCT06109454 — intervention group
Intervention type: DRUG
Intervention: Huaier granule
Description: The subjects voluntarily gave up postoperative adjuvant therapy, including chemotherapy, targeted therapy, immunotherapy, and radiation therapy, and agreed to take Huaier granules.The subjects took Huaier granules orally, one bag (10g) per time, three times a day. Until the end of the study, intolerable toxicity, withdrawal from the study for any reason or death, or when the researcher determines that there is no further benefit, whichever occurs first. Please refer to the drug manual for specific usage. It is recommended that patients start taking Huaier granules 1-2 weeks after surgery.
Study NCT06109454 — intervention group
Intervention type: OTHER
Intervention: Control
Description: The subjects received standard platinum dual drug chemotherapy.The subjects were treated with carboplatin injection (300mg/m2, intravenous injection, first day) combined with pemetrexed disodium (pathological type: adenocarcinoma, intravenous injection, 500mg/m2) or albumin bound paclitaxel (pathological type: squamous cell carcinoma, 260mg/m2, intravenous injection, first day) every three weeks, with a maximum of four cycles.
Study NCT04802018 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clinical decision support system based on non-invasive multimodal monitoring
Description: Non-invasive multimodal vital signs monitoring with the wearabl to monitor for a period of 10 days after the date of positive diagnosis to COVID-19. The device will be linked to the Home App, which will allow the sending of temperature, HR and RR data to the server every 15 minutes a day and the notification of symptoms by the patient three times a day.
Study NCT06394206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Specialized Unit
Description: The participant will be visited every three months for one year
Study NCT06394206 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Follow-Up
Description: The participant will be visited as usual, it means they will be visited at Digestive Consultation
Study NCT06394206 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Follow-Up
Description: The participant will be visited as usual, it means they will be visited at Digestive Consultation
Study NCT04661371 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Description: Method of operation~1. Surgery was started under general anesthesia~2. A trocar of 10 mm was placed on the navel, 5 mm under the blade, and 5 mm trocar was placed on the right upper abdomen.~3. Pneumoperitoneum was performed using CO2 gas in the abdominal cavity.~4. Dissection started from Calot's triangle and the operation was performed by retrograde cholecystectomy.~5. The excised gallbladder was placed in a laparoscopic pocket and extracted through the umbilicus.~6. The trocar was removed and the skin was sutured~On the 1st day after surgery, hematology, blood chemistry, urine, blood clotting, and chest x-rays were performed. (Inspection and treatment were performed according to the current clinical pathway of gallbladder surgery)
Study NCT05143528 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nilotinib BE 84mg
Description: 84 mg capsule
Study NCT05143528 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nilotinib BE 112 mg
Description: 112 mg capsule
Study NCT05143528 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo capsule
Study NCT04662112 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NASOX
Description: Oxalipatin 60 mg/m2 IV (2 h infusion) on Day 1, every 2 weeks Nal-IRI 50-60 mg/m2 IV (FBE, 90 min infusion) on Day 1, every 2 weeks S-1 40mg/m2 oral twice daily on Day 1-7, every 2 weeks